SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-030585
Filing Date
2017-06-01
Accepted
2017-06-01 16:02:24
Documents
3
Period of Report
2017-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v468188_8k.htm 8-K 36179
2 EXHIBIT 3.2 v468188_ex3-2.htm EX-3.2 5745
3 EXHIBIT 10.1 v468188_ex10-1.htm EX-10.1 80860
  Complete submission text file 0001144204-17-030585.txt   124342
Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 17884757
SIC: 2834 Pharmaceutical Preparations